DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $126,295,305 | +5.4% | 509,050 | +1.9% | 0.59% | +10.8% |
Q2 2023 | $119,857,440 | -7.7% | 499,406 | -3.1% | 0.53% | -12.4% |
Q1 2023 | $129,860,586 | -6.8% | 515,238 | -1.8% | 0.60% | -9.7% |
Q4 2022 | $139,271,979 | +2.1% | 524,723 | -0.7% | 0.67% | -6.2% |
Q3 2022 | $136,450,000 | +1.1% | 528,281 | -0.8% | 0.71% | +9.2% |
Q2 2022 | $134,968,000 | -14.6% | 532,376 | -1.2% | 0.65% | +1.1% |
Q1 2022 | $158,081,000 | -8.4% | 538,919 | +2.7% | 0.65% | -3.7% |
Q4 2021 | $172,668,000 | +10.3% | 524,810 | +2.1% | 0.67% | -1.3% |
Q3 2021 | $156,525,000 | +13.6% | 514,141 | +0.2% | 0.68% | +12.6% |
Q2 2021 | $137,738,000 | +18.5% | 513,260 | -0.6% | 0.60% | +12.1% |
Q1 2021 | $116,209,000 | -0.5% | 516,302 | -1.8% | 0.54% | -6.1% |
Q4 2020 | $116,756,000 | +2.3% | 525,596 | -0.8% | 0.57% | -8.9% |
Q3 2020 | $114,084,000 | +22.3% | 529,811 | +0.4% | 0.63% | +12.7% |
Q2 2020 | $93,309,000 | +28.7% | 527,674 | +0.7% | 0.56% | +8.1% |
Q1 2020 | $72,518,000 | -8.8% | 523,933 | +1.1% | 0.52% | +16.7% |
Q4 2019 | $79,535,000 | +10.2% | 518,211 | +3.7% | 0.44% | +2.3% |
Q3 2019 | $72,141,000 | +2.6% | 499,487 | +1.6% | 0.43% | +0.9% |
Q2 2019 | $70,281,000 | +10.2% | 491,751 | +1.8% | 0.43% | +4.9% |
Q1 2019 | $63,785,000 | +27.3% | 483,145 | -0.5% | 0.41% | +12.4% |
Q4 2018 | $50,094,000 | +0.7% | 485,782 | +6.1% | 0.36% | +14.8% |
Q3 2018 | $49,747,000 | +10.2% | 457,818 | +0.0% | 0.32% | +3.6% |
Q2 2018 | $45,160,000 | -0.2% | 457,639 | -1.0% | 0.31% | -0.6% |
Q1 2018 | $45,256,000 | +7.4% | 462,224 | +1.8% | 0.31% | +7.3% |
Q4 2017 | $42,141,000 | +8.6% | 454,009 | +0.4% | 0.29% | +3.2% |
Q3 2017 | $38,808,000 | +2.1% | 452,414 | +0.4% | 0.28% | -0.7% |
Q2 2017 | $38,027,000 | +3.5% | 450,608 | +4.9% | 0.28% | +0.7% |
Q1 2017 | $36,754,000 | +7.2% | 429,721 | -2.5% | 0.28% | +0.4% |
Q4 2016 | $34,290,000 | -3.3% | 440,516 | -2.6% | 0.28% | -5.8% |
Q3 2016 | $35,470,000 | -23.2% | 452,485 | -1.1% | 0.29% | -25.0% |
Q2 2016 | $46,208,000 | +9.0% | 457,501 | +2.4% | 0.39% | +6.8% |
Q1 2016 | $42,376,000 | +9.1% | 446,725 | +6.8% | 0.37% | +7.6% |
Q4 2015 | $38,849,000 | +29.6% | 418,274 | +18.9% | 0.34% | +22.7% |
Q3 2015 | $29,984,000 | +27.5% | 351,888 | +28.1% | 0.28% | +35.6% |
Q2 2015 | $23,517,000 | +3.6% | 274,767 | +2.8% | 0.20% | +4.6% |
Q1 2015 | $22,700,000 | -1.7% | 267,371 | -0.7% | 0.20% | -0.5% |
Q4 2014 | $23,089,000 | +13.4% | 269,389 | +0.5% | 0.20% | +5.9% |
Q3 2014 | $20,361,000 | +7.1% | 267,972 | +11.0% | 0.19% | +8.1% |
Q2 2014 | $19,008,000 | +15.7% | 241,435 | +10.2% | 0.17% | +11.7% |
Q1 2014 | $16,428,000 | +4.4% | 219,036 | +7.5% | 0.15% | +1.3% |
Q4 2013 | $15,733,000 | +28.8% | 203,800 | +15.6% | 0.15% | +20.6% |
Q3 2013 | $12,218,000 | +25.4% | 176,260 | +14.5% | 0.13% | +21.2% |
Q2 2013 | $9,744,000 | – | 153,939 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |